{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T14:40:20Z","timestamp":1756305620431,"version":"3.44.0"},"reference-count":7,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2021,5,10]]},"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:p>Two patients receiving oral etoposide therapy developed <jats:italic>Pneumocystis jirovecii<\/jats:italic> pneumonia during chemotherapy with significant lymphopenia without corticosteroid use. In this commentary we discuss cellular mechanisms by which etoposide induced CD4+ T lymphocyte dysfunction and reduced survival may lead to predisposition to <jats:italic>P. jirovecii<\/jats:italic> infection.<\/jats:p>","DOI":"10.1136\/bcr-2021-242485","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T13:13:01Z","timestamp":1623330781000},"page":"e242485","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["<i>Pneumocystis jirovecii<\/i> pneumonia as a complication of etoposide therapy"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3822-0669","authenticated-orcid":false,"given":"Maria Alejandra","family":"Mendoza","sequence":"first","affiliation":[{"name":"Internal Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2507-9347","authenticated-orcid":false,"given":"Sunil","family":"Iyer","sequence":"additional","affiliation":[{"name":"Internal Medicine, University of Miami, Miami Beach, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose F.","family":"Camargo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, University of Miami, Miami, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale W.","family":"Benedetto","sequence":"additional","affiliation":[{"name":"Deparment of Medicine, Division of Medical Oncology, University of Miami Miller School of Medicine, Miami, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,6,10]]},"reference":[{"key":"2025082707101864000_14.6.e242485.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2006.11.005"},{"key":"2025082707101864000_14.6.e242485.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(98)00228-7"},{"key":"2025082707101864000_14.6.e242485.3","unstructured":"TOPOSAR- etoposide injection, solution, concentrate, 2017 Etoposide injection USP, I. Teva parenteral medicines. Available: https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=c9080cf5-4fc3-4cf9-a241-6e40a6fddc75 [Accessed on October 12, 2020]."},{"key":"2025082707101864000_14.6.e242485.4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/stem.140018","article-title":"The importance of drug scheduling in cancer chemotherapy: etoposide as an example","volume":"14","author":"Hande","year":"1996","journal-title":"Stem Cells"},{"key":"2025082707101864000_14.6.e242485.5","doi-asserted-by":"publisher","DOI":"10.2217\/fmb.09.116"},{"key":"2025082707101864000_14.6.e242485.6","doi-asserted-by":"crossref","first-page":"1242.e11","DOI":"10.1016\/j.amjmed.2014.07.010","article-title":"Incidence of Pneumocystis jiroveci pneumonia among groups at risk in HIV-negative patients","volume":"127","author":"Fillatre","year":"2014","journal-title":"Am J Med"},{"key":"2025082707101864000_14.6.e242485.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2012.08.006"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2021-242485","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T14:10:24Z","timestamp":1756303824000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2021-242485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":7,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6,10]]},"published-print":{"date-parts":[[2021,6]]}},"alternative-id":["10.1136\/bcr-2021-242485"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2021-242485","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2021,6]]}}}